Loading icon
Research

EBSCO Research

Current News

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial 2023-11-09 04:00:00

Potential Risk of Overlooking Biased Reporting of Vaccination against Novel Coronavirus Disease 2019: Lessons from Japan's Experience with the Human Papillomavirus Vaccine

Potential Risk of Overlooking Biased Reporting of Vaccination against Novel Coronavirus Disease 2019: Lessons from Japan's Experience with the Human Papillomavirus Vaccine 2023-11-09 04:00:00

Does doffing the FEES Box generate a significant cloud of particles after aerosol-generating procedures? A proof-of-concept study

Does doffing the FEES Box generate a significant cloud of particles after aerosol-generating procedures? A proof-of-concept study 2023-11-09 04:00:00

Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination

Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination 2023-11-09 04:00:00

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data

Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data 2023-11-09 04:00:00

PICO Search Aid